Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC 50242-041-64
Published June 5, 2024 · Recall initiated: May 20, 2024
Summary
FDA records drug Class II recall D-0509-2024, published June 5, 2024 and initiated May 20, 2024. Recalling firm: Genentech, Inc.; Status: Terminated; Reported quantity: Lot:3618858 = 105,759; Lot:3618873 =90,359; Lot: Lot #: 3618858, 3618873, Exp. Date 01/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.
What to do
Voluntary: Firm initiated · Letter
Get an email if CATHFLO ACTIVASE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CATHFLO ACTIVASE
- Manufacturer
- Genentech, Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 3618858, 3618873, Exp. Date 01/31/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAZoledronic Acid Injection 5mg/100mL Sterile Solution, 100mL Single-Dose vials, Rx only, Distributor: Dr.June 5, 2024
- FDATirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By:June 5, 2024
- FDABrand Name: MEDLINE Product Name: SYR 20ML/L PURPLE Model/Catalog Number: 91843 Product Description:May 29, 2024
- FDABrand Name: MEDLINE Product Name: SYR 10ML/L BLUE CONTRAST Model/Catalog Number: 91848 Product Description:May 29, 2024
- FDABrand Name: MEDLINE Product Name: SYR 20ML/L WHITE HEP FLUSH Model/Catalog Number: 91862 Product Description:May 29, 2024
- FDAcathflo activase (ALTEPLASE) 2 mg Rx Only NDC 50242-041-64 GenentechJune 2, 2021
Questions about this recall
Was Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC 50242-041-64 recalled?
Yes. FDA published recall D-0509-2024 on June 5, 2024. Reported hazard: Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CATHFLO ACTIVASE.